We are monitoring the impact of COVID-19 on Europe Immunohistochemistry Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2739
Share on
Share on

Europe Immunohistochemistry Market Research Report – Segmented By Product, Application, End User & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts 2019-2024

Pulished: February, 2020
ID: 2739
Pages: 140

The Europe Immunohistochemistry Market size was worth USD 440 million in 2019 and estimated to be growing at a CAGR of 7.45%, to reach USD 630 million by 2024.

Immunohistochemistry is a diagnosis process in which a fresh or stored cancer tissue that is removed out during biopsy is stained. This diagnostic method helps in checking the presence of hormone receptors on the surfaces of cancer cells. Immunohistochemistry is mainly used for the diagnosis of cancers, especially tumour antibodies. It is a vital application in the field of medicine as it helps doctors to know the tissue distribution of an antibody.

The developing healthcare infrastructure, rising disposable income, and advancement in medical technology are driving the growth of the Immunotherapy market in Europe. The growing prevalence of cancer actively encourages this region, and various other chronic diseases are also majorly propelling market growth. Immunohistochemistry has immense popularity in the area of clinical diagnostics, which is used in the diagnosis of chronic diseases such as infectious diseases, cardiovascular diseases, cancer and autoimmune disorders and others.

However, huge capital and time requirements and uncertain reimbursement scenarios are significant factors that hamper the growth of this market. Several limitations related to immunohistochemistry techniques and the expensive cost of automated IHC instruments are anticipated to restrains market growth in Europe. Automated immunohistochemistry instruments for disease diagnosis take high setup costs are hindering the market growth.

This research report on Europe Immunohistochemistry Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2024.

  • By Product: Antibodies, Reagents, Equipment, and Kits.
  • By Application: Diagnostics and Drug Testing.
  • By End User: Hospitals and Diagnostic Laboratories and Research Institutes.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

Regional Analysis

European IHC Market was the world’s second-leading regional market in 2019, and the United Kingdom Immunohistochemistry market was the top-performing regional market in Europe. Factors such as rising drug discovery and development activities and increasing prevalence of chronic diseases are anticipated to drive the immunohistochemistry (IHC) market growth in the U.K.

Germany Immunohistochemistry market showing significant growth due to the rising number of diagnostic centres, and increasing physician awareness and demand for histopathology are anticipated to fuel the growth of this market in the coming years. Additional to this, rapid technological developments in the IVD industry and increasing healthcare expenditure are expected to fuel the growth of this market.

Promising Companies Operating the Europe Immunohistochemistry Market Profiled in the Report are F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.,

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Antibodies              

                                5.1.3 Reagents 

                                5.1.4 Equipment              

                                5.1.5 Kits             

                                5.1.6  Y-o-Y Growth Analysis, By Product              

                                5.1.7  Market Attractiveness Analysis, By Product            

                                5.1.8  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Diagnostics              

                                                5.2.2.1 Cancer

                                                5.2.2.2 Infectious Diseases

                                                5.2.2.3 Cardiovascular Diseases

                                                5.2.2.4 Autoimmune Diseases

                                                5.2.2.5 Diabetes Milletus

                                                5.2.2.6 Nephrological Diseases

                                5.2.3 Drug testing            

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application       

                                5.2.6 Market Share Analysis, By Application        

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals and Diagnostics Laboratories       

                                5.3.3 Research Institutes             

                                5.3.4 Y-o-Y Growth Analysis, By End Users           

                                5.3.5  Market Attractiveness Analysis, By End Users        

                                5.3.6  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 F. Hoffman La Roche AG                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Agilent Technologies                              

                8.4 Thermo Fischer Scientific Inc.                             

                8.5 Merck Millipore                        

                8.6 Bio-Rad Laboratories                              

                8.7 Cell Signalling Technology                     

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  2. Europe Antibodies Market By Region, From 2019-2024 ( USD Million )
  3. Europe Reagents Market By Region, From 2019-2024 ( USD Million )
  4. Europe Equipment Market By Region, From 2019-2024 ( USD Million )
  5. Europe Kits Market By Region, From 2019-2024 ( USD Million )
  6. Europe Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  7. Europe Diagnostics Market By Region, From 2019-2024 ( USD Million )
  8. Europe Drug Testing Market By Region, From 2019-2024 ( USD Million )
  9. Europe Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  10. Europe Hospitals and Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  11. Europe Research Institutes Market By Region, From 2019-2024 ( USD Million )
  12. U.K. Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  13. U.K. Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  14. U.K. Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  15. Germany Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  16. Germany Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  17. Germany Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  18. France Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  19. France Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  20. France Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  21. Italy Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  22. Italy Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  23. Italy Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  24. Spain Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  25. Spain Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  26. Spain Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  27. Europe Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  28. Europe Cancer Market By Region, From 2019-2024 ( USD Million )
  29. Europe Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  30. Europe Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  31. Europe Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  32. Europe Diabetes Mellitus Market By Region, From 2019-2024 ( USD Million )
  33. Europe Nephrological Diseases Market By Region, From 2019-2024 ( USD Million )
  34. U.K. Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  35. Germany Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  36. France Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  37. Italy Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  38. Spain Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  39. Europe Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  40. Europe Cancer Market By Region, From 2019-2024 ( USD Million )
  41. Europe Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  42. Europe Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  43. Europe Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  44. Europe Diabetes Mellitus Market By Region, From 2019-2024 ( USD Million )
  45. Europe Nephrological Diseases Market By Region, From 2019-2024 ( USD Million )
  46. U.K. Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  47. Germany Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  48. France Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  49. Italy Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  50. Spain Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample